First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
35.38
-0.26 (-0.74%)
Jun 18, 2026, 4:00 PM EDT - Market closed

FTXH Holdings Information

FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Eli Lilly and Company stock at 7.72%, AbbVie at 6.96%, Johnson & Johnson at 6.89%, Merck & Co. at 6.81%, and Bristol-Myers Squibb Company at 6.47%.

Total Holdings
51
Top 10 Percentage
52.89%
Asset Class
Equity
ETF Category
Health
Assets
34.19M
PE Ratio
20.20

Breakdown by Country

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company7.72%2,351
2ABBVAbbVie Inc.6.96%10,655
3JNJJohnson & Johnson6.89%9,953
4MRKMerck & Co., Inc.6.81%19,970
5BMYBristol-Myers Squibb Company6.47%39,646
6VTRSViatris Inc.3.85%82,811
7BIIBBiogen Inc.3.78%6,445
8CAHCardinal Health, Inc.3.61%5,394
9PFEPfizer Inc.3.42%44,715
10VRTXVertex Pharmaceuticals Incorporated3.37%2,489
11AMGNAmgen Inc.3.21%3,185
12GILDGilead Sciences, Inc.3.08%8,301
13UTHRUnited Therapeutics Corporation2.97%1,824
14REGNRegeneron Pharmaceuticals, Inc.2.84%1,582
15JAZZJazz Pharmaceuticals plc2.51%3,746
16INCYIncyte Corporation2.24%7,659
17ZTSZoetis Inc.2.15%9,431
18ILMNIllumina, Inc.1.92%4,093
19EXELExelixis, Inc.1.78%11,505
20PTCTPTC Therapeutics, Inc.1.41%6,099
21NBIXNeurocrine Biosciences, Inc.1.38%2,944
22MEDPMedpace Holdings, Inc.1.31%968
23CRLCharles River Laboratories International, Inc.1.28%2,380
24ALKSAlkermes plc1.23%9,379
25BMRNBioMarin Pharmaceutical Inc.1.15%7,071
Showing 25 of 51 holdings
Subscribe to see the full list
As of Jun 17, 2026